Previous 10 | Next 10 |
New Ventures Funds Rebrands as Scientia Ventures PR Newswire NEW YORK, Oct. 2, 2020 NEW YORK , Oct. 2, 2020 /PRNewswire/ -- New Ventures Funds has launched a new corporate brand identity and changed its name to Scientia Ventures. The new website for the firm ...
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 08/7/2020. Please visit our Tracking Ole Andreas Halvorsen&...
Pharma continues to be a sector of interest in light of the pandemic. Although the sector's performance has been somewhat muted, in part by the concerns around the 'most favoured nation' drug pricing approach for drugs covered by Medicare Part B, it still remains the high margin and missio...
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that it has closed an offering of $6 billion senior unsecured notes, comprised of the following tranches (collectively, the “Notes”): $1 billion aggregate principal amount of 0.7...
NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2020 of $0.15 per class A share. The dividend will be paid on September 30, 2020, to shareholders of record at the clos...
Royalty Pharma (NASDAQ: RPRX ) has priced its previously announced offering of $6B senior unsecured notes, comprised of 6 tranches including: More news on: Royalty Pharma plc, Healthcare stocks news, , Read more ...
NEW YORK, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc announced today that it has priced an offering of $6 billion senior unsecured notes, comprised of the following tranches (collectively, the “Notes”): $1 billion aggregate principal amount of 0.75% Senior Notes ...
Royalty Pharma ( RPRX +1.3% ) intends to offer senior unsecured notes in multiple tranches in a private offering; guaranteed on a senior unsecured basis by Royalty Pharma Holdings. More news on: Royalty Pharma plc, Healthcare stocks news, , Stocks on the move, Read more ... ...
NEW YORK, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc announced today that it intends to offer, subject to market and other conditions, senior unsecured notes in multiple tranches (the “Notes”) in a private offering exempt from registration in accordance with Rule 144...
Royalty Pharma ( RPRX ) went public in June as I concluded that the company is an interesting business and stock to follow. I noted that the company has seen steady growth, is very profitable, leverage is modest, pro-forma earnings multiples look compelling, and on top of that, the company...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins Royalty Pharma from Hudson Bay Capital, where she was a Managing Director and Head of Colleague Experie...
2024-07-24 08:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...